Outcome based subgroup analysis: A neglected concern

Trials

Volumn 10, Issue , 2009, Pages

  Hirji, Karim F ^a   Fagerland, Morten W ^b  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; LACTOBACILLUS EXTRACT; LORCAINIDE; PLACEBO; PROBIOTIC AGENT; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE HEART INFARCTION; ACUTE OTITIS MEDIA; ARTICLE; ATOPIC DERMATITIS; AWARENESS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DATA ANALYSIS; ERYTHROCYTE TRANSFUSION; HUMAN; HYPOTHESIS; INTENSIVE CARE; LUNG CANCER; MEDICAL PRACTICE; MEDICAL RESEARCH; METHODOLOGY; MOBILIZATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; SELECTIVE ATTENTION; SYSTEMATIC ERROR; EPIDEMIOLOGY; REPRODUCIBILITY; STATISTICAL ANALYSIS; STATISTICS; SURVIVAL; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67649977705     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-10-33     Document Type: Article

References (31)

1. Andersen B Methodological Errors in Medical Research: An Incomplete Catalogue Oxford, England: Blackwell Scientific Publications 1990
2. Assmann SF Pocock SJ Enos LE Kasten LE Subgroup analysis and other (mis)uses of baseline data in clinical trials Lancet 2000, 355(9209):1064-1069. 10.1016/S0140-6736(00)02039-0 10744093
3. Bhandari M Devereaux PJ Li P Mah D Lim K Schünemann HJ Tornetta P III Misuse of baseline comparison tests and subgroup analyses in surgical trials Clinical Orthopaedics and Related Research 2006, 447:247-251. 10.1097/01.blo.0000218736.23506.fe
4. Fletcher J Subgroup analyses: How to avoid being misled BMJ 2007, 335:96-97. 1914513 17626964 10.1136/bmj.39265.596262.AD
5. Hernandez AV Boersma E Murray GD Habbema JD Steyerberg EW Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading? American Heart Journal 2006, 151:257-264. 10.1016/ j.ahj.2005.04.020 16442886
6. Lagakos SW The challenge of subgroup analyses - reporting without distorting New England Journal of Medicine 2006, 354:1667-1669. 10.1056/ NEJMp068070 16625007
7. Oxman AD Guyatt GH A consumer's guide to subgroup analyses Annals of Internal Medicine 1992, 116:78-84. 1530753
8. Pfeffer MA Jarcho JA The charisma of subgroups and the subgroups of CHARISMA New England Journal of Medicine 2006, 354:1744-1746. 10.1056/ NEJMe068061 16531617
9. Pocock SJ Assmann SE Enos LE Kasten LE Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems Statistics in Medicine 2002, 21:2917-2930. 10.1002/ sim.1296 12325108
10. Rothwell PM Treating Individuals 2. Subgroup analysis in randomised controlled trials: Importance, indications, and interpretation Lancet 2005, 365:176-186. 10.1016/S0140-6736(05)17709-5 15639301
11. Schulz KF Grimes DA Multiplicity in randomised trials II: Subgroup and interim analyses Lancet 2005, 365:1657-1661. 10.1016/ S0140-6736(05)66516-6 15885299
12. Wang R Lagakos SW Ware JH Hunter DJ Drazen JM Statistics in medicine - reporting of subgroup analyses in clinical trials New England Journal of Medicine 2007, 357:2189-2194. 10.1056/NEJMsr077003 18032770
13. Yusuf S Wittes J Probstfield J Tyroler HA Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials Journal of the American Medical Association 1991, 266:93-98. 2046134 10.1001/jama.266.1.93
14. Julian DG Debate: A subversive view of subsets - a dissident clinician's opinion Current Controlled Trials in Cardiovascular Medicine 2000, 1:28-30. 59593 11714403 10.1186/CVM-1-1-028
15. Sleight P Debate: Subgroup analyses in clinical trials - fun to look at, but don't believe them! Current Controlled Trials in Cardiovascular Medicine 2000, 1:25-27. 59592 11714402 10.1186/CVM-1-1-025
16. Altman DG Within trial variation - a false trail? Journal of Clinical Epidemiology 1998, 51:301-303. 10.1016/S0895-4356(98)00005-5 9539885
17. Feinstein A The problem of cogent subgroups: A clinicostatistical tragedy Journal of Clinical Epidemiology 1998, 51:297-299. 10.1016/ S0895-4356(98)00004-3 9539884
18. Cook DI Gebski VJ Keech AC Subgroup analysis in clinical trials Medical Journal of Australia 2004, 180:289-291. 15012568
19. Sundstrøm S Bremnes RM Kaasa S Aasebø U Hatlevoll R Dahle R Boye N Wang M Vigander T Vilsvik J Skovlund E Hannisdal E Aamdal S Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: Results from a randomized phase III trial with 5 years' follow-up Journal of Clinical Oncology 2002, 20:4665-4672. 10.1200/JCO.2002.12.111 12488411
20. Corwin HL Gettinger A Fabian TC May A Pearl RG Heard S An R Bowers PJ Burton P Klausner MA Corwin MJ Efficacy and safety of epoetin alfa in critically ill patients New England Journal of Medicine 2007, 357:965-976. 10.1056/NEJMoa071533 17804841
21. Bernhardt J Dewey H Thrift A Collier J Donnan G A very early rehabilitation trial for stroke (AVERT) - Phase II safety and feasibility Stroke 2008, 39:390-396. 10.1161/STROKEAHA.107.492363 18174489
22. Kopp MV Hennemuth I Heinzmann A Urbanek R Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation Pediatrics 2008, 121:e850-856. 10.1542/peds.2007-1492 18332075
23. McCormick DP Chonmaitree T Pittman C Saeed K Friedman NR Uchida T Baldwin CD Nonsevere acute otitis media: A clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment Pediatrics 2005, 115:1455-1465. 10.1542/peds.2004-1665 15930204
24. Cowley AJ Skene A Stainer R Hampton JR The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias International Journal of Cardiology 1993, 40:160-166. 10.1016/0167-5273(93)90279-P
25. Molenberghs G Kenward MG Missing Data in Clinical Studies New York: Wiley 2007
26. Fairclough DL Design and Analysis of Quality of Life Studies in Clinical Trials Boca Raton, Florida: Chapman & Hall/CRC 2002
27. Fayers PM Machin D Quality of Life: The assessment, analysis and interpretation of patient-reported outcomes Chichester, England: Wiley 2 2007
28. Fielding S MacIennan G Cook JA Ramsay CR A review of RCTs in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes Trials 2008, 9(51). 18694492
29. Frangakis CE Rubin DB Principal stratification in causal inference Biometrics 2002, 58:21-29. 10.1111/j.0006-341X.2002.00021.x 11890317
30. Freemantle N Calvert M Wood J Eastaugh J Griffin C Composite outcomes in randomized trials Journal of the American Medical Association 2003, 289:2554-2559. 10.1001/jama.289.19.2554 12759327
31. Moore DS Statistics: Concepts and Controversies New York: WH Freeman and Company 3 1991